301281 科源制药
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)2.1234.4958.32519.20220.236
总资产报酬率 ROA (%)1.9934.0007.26215.07115.358
投入资产回报率 ROIC (%)1.9884.3268.15418.63519.474

边际利润分析
销售毛利率 (%)52.08244.26947.25240.93642.101
营业利润率 (%)9.25814.72117.90022.16721.341
息税前利润/营业总收入 (%)10.05513.61616.73121.58121.427
净利润/营业总收入 (%)10.32812.99817.21220.61118.573

收益指标分析
经营活动净收益/利润总额(%)74.84974.02883.43496.57492.525
价值变动净收益/利润总额(%)14.44519.69015.9830.0000.000
营业外收支净额/利润总额(%)12.275-3.887-0.4780.1310.107

偿债能力分析
流动比率 (X)5.6275.7667.9072.6171.836
速动比率 (X)4.2844.6906.9351.9871.056
资产负债率 (%)14.59712.4239.45120.26122.971
带息债务/全部投入资本 (%)5.3883.926-0.520-1.119-1.590
股东权益/带息债务 (%)1,729.9952,398.978-18,929.749-8,633.711-6,137.068
股东权益/负债合计 (%)685.091704.511958.081393.551335.331
利息保障倍数 (X)-20.163-24.601-15.447-35.060340.459

营运能力分析
应收账款周转天数 (天)64.69237.65432.43824.03117.141
存货周转天数 (天)260.640165.071134.162106.221116.260